|
1
|
Urasaki Y, Takebayashi Y and Pommier Y:
Activity of a novel camptothecin analogue, homocamptothecin, in
camptothecin-resistant cell lines with topoisomerase I alterations.
Cancer Res. 60:6577–6580. 2000.PubMed/NCBI
|
|
2
|
Zhang R, Li Y, Cai Q, Liu T, Sun H and
Chambless B: Preclinical pharmacology of the natural product
anticancer agent 10-hydroxycamptothecin, an inhibitor of
topoisomerase I. Cancer Chemother Pharmacol. 41:257–267. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang G, Ding L, Renegar R, Wang X, Lu Q,
Huo S and Chen YH: Hydroxycamptothecin-loaded Fe3O4 nanoparticles
induce human lung cancer cell apoptosis through caspase-8 pathway
activation and disrupt tight junctions. Cancer Sci. 102:1216–1222.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nie F, Cao J, Tong J, Zhu M, Gao Y and Ran
Z: Role of Raf-kinase inhibitor protein in colorectal cancer and
its regulation by hydroxycamptothecine. J Biomed Sci. 22:562015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu Z, Zhu G, Getzenberg RH and Veltri RW:
The upregulation of PI3K/Akt and MAP kinase pathways is associated
with resistance of microtubule-targeting drugs in prostate cancer.
J Cell Biochem. 116:1341–1349. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bian Z, Yu Y, Quan C, Guan R, Jin Y, Wu J,
Xu L, Chen F, Bai J, Sun W and Fu S: RPL13A as a reference gene for
normalizing mRNA transcription of ovarian cancer cells with
paclitaxel and 10-hydroxycamptothecin treatments. Mol Med Rep.
11:3188–3194. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fu T, Wang L, Jin XN, Sui HJ, Liu Z and
Jin Y: Hyperoside induces both autophagy and apoptosis in non-small
cell lung cancer cells in vitro. Acta Pharmacol Sin. 37:505–518.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mizushima N, Yoshimori T and Levine B:
Methods in mammalian autophagy research. Cell. 140:313–326. 2016.
View Article : Google Scholar
|
|
11
|
Baehrecke EH: Autophagy: Dual roles in
life and death? Nat Rev Mol Cell Biol. 6:505–510. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang H and Baehrecke EH: Eaten alive:
Novel insights into autophagy from multicellular model systems.
Trends Cell Biol. 25:376–387. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Weckman A, Rotondo F, Di Ieva A, Syro LV,
Butz H, Cusimano MD and Kovacs K: Autophagy in endocrine tumors.
Endocr Relat Cancer. 22:R205–R218. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Djavaheri-Mergny M, Maiuri M and Kroemer
G: Cross talk between apoptosis and autophagy by caspase-mediated
cleavage of Beclin 1. Oncogene. 29:1717–1719. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kang R, Zeh HJ, Lotze MT and Tang D: The
Beclin 1 network regulates autophagy and apoptosis. Cell Death
Differ. 18:571–580. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pan X, Zhang X, Sun H, Zhang J, Yan M and
Zhang H: Autophagy inhibition promotes 5-fluorouraci-induced
apoptosis by stimulating ROS formation in human non-small cell lung
cancer A549 cells. PLoS One. 8:e566792013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ravikumar B, Berger Z, Vacher C, O'Kane CJ
and Rubinsztein DC: Rapamycin pre-treatment protects against
apoptosis. Hum Mol Genet. 15:1209–1216. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cui Q, Tashiro S, Onodera S, Minami M and
Ikejima T: Autophagy preceded apoptosis in oridonin-treated human
breast cancer MCF-7 cells. Biol Pharm Bull. 30:859–864. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Iwamaru A, Kondo Y, Iwado E, Aoki H,
Fujiwara K, Yokoyama T, Mills GB and Kondo S: Silencing mammalian
target of rapamycin signaling by small interfering RNA enhances
rapamycin-induced autophagy in malignant glioma cells. Oncogene.
26:1840–1851. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cheng Y, Chen G, Hu M, Huang J, Li B, Zhou
L and Hong L: Has-miR-30a regulates autophagic activity in cervical
cancer upon hydroxycamptothecinexposure. Biomed Pharmacother.
75:67–74. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Desai SD, Reed RE, Babu S and Lorio EA:
ISG15 deregulates autophagy in genotoxin-treated ataxia
telangiectasia cells. J Biol Chem. 288:2388–2402. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Eskelinen EL, Prescott AR, Cooper J,
Brachmann SM, Wang L, Tang X, Backer JM and Lucocq JM: Inhibition
of autophagy in mitotic animal cells. Traffic. 3:878–893. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vilgelm AE, Pawlikowski JS, Liu Y, Hawkins
OE, Davis TA, Smith J, Weller KP, Horton LW, McClain CM, Ayers GD,
et al: Mdm2 and aurora kinase a inhibitors synergize to block
melanoma growth by driving apoptosis and immune clearance of tumor
cells. Cancer Res. 75:181–193. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhu M, Xu Y, Ge M, Gui Z and Yan F:
Regulation of UHRF1 by microRNA-9 modulates colorectal cancer cell
proliferation and apoptosis. Cancer Sci. 106:833–839. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hamedani FS, Cinar M, Mo Z, Cervania MA,
Amin HM and Alkan S: Crizotinib (PF-2341066) induces apoptosis due
to downregulation of pSTAT3 and BCL-2 family proteins in NPM-ALK(+)
anaplastic large cell lymphoma. Leuk Res. 38:503–508. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Edlich F, Banerjee S, Suzuki M, Cleland
MM, Arnoult D, Wang C, Neutzner A, Tjandra N and Youle RJ: Bcl-x(L)
retrotranslocates Bax from the mitochondria into the cytosol. Cell.
145:104–116. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rossé T, Olivier R, Monney L, Rager M,
Conus S, Fellay I, Jansen B and Borner C: Bcl-2 prolongs cell
survival after Bax-induced release of cytochrome c. Nature.
391:496–499. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lalier L, Cartron PF, Juin P, Nedelkina S,
Manon S, Bechinger B and Vallette FM: Bax activation and
mitochondrial insertion during apoptosis. Apoptosis. 12:887–896.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Guo B, Zhai D, Cabezas E, Welsh K,
Nouraini S, Satterthwait AC and Reed JC: Humanin peptide suppresses
apoptosis by interfering with Bax activation. Nature. 423:456–461.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tallman MS: New strategies for the
treatment of acute myeloid leukemia including antibodies and other
novel agents. Hematology Am Soc Hematol Educ Program. 1–150.
2005.PubMed/NCBI
|
|
31
|
Chen XP, Ren XP, Lan JY, Chen YG and Shen
ZJ: Analysis of HGF, MACC1, C-met and apoptosis-related genes in
cervical carcinoma mice. Mol Biol Rep. 41:1247–1256. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yuan Y, Wang H, Wei Z and Li W: Impaired
autophagy in hilar mossy cells of the dentate gyrus and its
implication in schizophrenia. J Genet Genomics. 42:1–8. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gewirtz DA: The four faces of autophagy:
Implications for cancer therapy. Cancer Res. 74:647–651. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Maiuri MC, Zalckvar E, Kimchi A and
Kroemer G: Self-eating and self-killing: Crosstalk between
autophagy and apoptosis. Nat Rev Mol Cell Biol. 8:741–752. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Maiuri MC, Le Toumelin G, Criollo A, Rain
JC, Gautier F, Juin P, Tasdemir E, Pierron G, Troulinaki K,
Tavernarakis N, et al: Functional and physical interaction between
Bcl-XL and a BH3-like domain in Beclin-1. EMBO J. 26:2527–2539.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yorimitsu T and Klionsky DJ: Autophagy:
Molecular machinery for self-eating. Cell Death Differ. 12 Suppl
2:S1542–S1552. 2005. View Article : Google Scholar
|
|
37
|
Mizushima N, Levine B, Cuervo AM and
Klionsky DJ: Autophagy fights disease through cellular
self-digestion. Nature. 451:1069–1075. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Schreiber RD, Old LJ and Smyth MJ: Cancer
immunoediting: Integrating immunity's roles in cancer suppression
and promotion. Science. 331:1565–1570. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Michaud M, Martins I, Sukkurwala AQ,
Adjemian S, Ma Y, Pellegatti P, Shen S, Kepp O, Scoazec M, Mignot
G, et al: Autophagy-dependent anticancer immune responses induced
by chemotherapeutic agents in mice. Science. 334:1573–1577. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cheng YX, Zhang QF, Pan F, Huang JL, Li
BL, Hu M, Li MQ and Chen Ch: Hydroxycamptothecin shows antitumor
efficacy on HeLa cells via autophagy activation mediated apoptosis
in cervical cancer. Eur J Gynaecol Oncol. 37:238–243.
2016.PubMed/NCBI
|
|
41
|
White E and DiPaola RS: The double-edged
sword of autophagy modulation in cancer. Clin Cancer Res.
15:5308–5316. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lin L and Baehrecke EH: Autophagy, cell
death, and cancer. Mol Cell Oncol. 2:e9859132015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Bailly C: Homocamptothecins: Potent
topoisomerase I inhibitors and promising anticancer drugs. Crit Rev
Oncol Hematol. 45:91–108. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Levine B and Kroemer G: Autophagy in the
pathogenesis of disease. Cell. 132:27–42. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yan J, Yang H, Wang G, Sun L, Zhou Y, Guo
Y, Xi Z and Jiang X: Autophagy augmented by troglitazone is
independent of EGFR transactivation and correlated with
AMP-activated protein kinase signaling. Autophagy. 6:67–73. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Levine B and Klionsky DJ: Development by
self-digestion: Molecular mechanisms and biological functions of
autophagy. Dev Cell. 6:463–477. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Amaravadi RK, Lippincott-Schwartz J, Yin
XM, Weiss WA, Takebe N, Timmer W, DiPaola RS, Lotze MT and White E:
Principles and current strategies for targeting autophagy for
cancer treatment. Clin Cancer Res. 17:654–666. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Sui X, Chen R, Wang Z, Huang Z, Kong N,
Zhang M, Han W, Lou F, Yang J, Zhang Q, et al: Autophagy and
chemotherapy resistance: A promising therapeutic target for cancer
treatment. Cell Death Dis. 4:e8382013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Liu Z, Shi A, Song D, Han B, Zhang Z, Ma
L, Liu D and Fan Z: Resistin confers resistance to
doxorubicin-induced apoptosis in human breast cancer cells through
autophagy induction. Am J Cancer Res. 7:574–583. 2017.PubMed/NCBI
|
